Cytosorbents Corp. (CTSO)
NCM · Common · CUSIP 23283X206
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CTSO and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
23283X206
Market Cap
Small Cap
Business: Cytosorbents Corp. is a critical care immunotherapy company using blood purification to treat life-threatening illnesses. With its flagship product, CytoSorb, approved in the European Union and marketed in 20 countries worldwide, CytoSorbents is committed to helping save the lives and improve the outcomes of critically-ill patients and patient undergoing cardiac surgery around the world.

Company Contact

CEO
Phillip P. Chan
CFO
Peter J. Mariani
Headquarters
305 College Road East, Princeton NJ 08540
Phone
732-329-8885
Fax
732-329-8650
Investor Relations
Terri Anne Powers · 732-329-8885 · tpowers@cytosorbents.com
General Email
info@cytosorbents.com
SEC EDGAR Filings
View filings »